Filing Flows › Lipocine (LPCN) › Who owns the stock
Who owns Lipocine (LPCN) stock
36 funds reported Lipocine (LPCN) shares in their latest 13F filings, worth $9.3M in all. The largest holder is Squadron Capital Management LLC ($2.1M). Last quarter 18 funds added to their stakes and 17 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Squadron Capital Management LLC | 810,000 | $2.1M | increase | 2026-06-30 |
| Vanguard Group | 221,867 | $1.8M | unchanged | 2025-12-31 |
| Ikarian Capital, LLC | 508,556 | $1.3M | unchanged | 2026-06-30 |
| Eversept Partners, LP | 294,989 | $755K | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 230,823 | $591K | increase | 2026-06-30 |
| Acadian Asset Management LLC | 170,417 | $435K | new | 2026-06-30 |
| Boothbay Fund Management, LLC | 140,487 | $360K | unchanged | 2026-06-30 |
| Jane Street Group, LLC | 95,227 | $244K | increase | 2026-06-30 |
| BlackRock | 89,272 | $229K | unchanged | 2026-06-30 |
| Two Sigma Investments, LP | 84,887 | $217K | increase | 2026-06-30 |
| Citadel Advisors LLC | 81,221 | $208K | increase | 2026-06-30 |
| Seven Fleet Capital Management LP | 78,842 | $202K | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 74,477 | $191K | increase | 2026-06-30 |
| Renaissance Technologies LLC | 69,209 | $177K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 54,539 | $140K | increase | 2026-06-30 |
Lipocine's latest quarter
Lipocine, Q3 2026: revenue $2.3M (20× year over year), operating margin -37.9%, net loss $666K, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most LPCN stock?
By the latest 13F filings: Squadron Capital Management LLC ($2.1M); Vanguard Group ($1.8M); Ikarian Capital, LLC ($1.3M); Eversept Partners, LP ($755K); Vanguard Capital Management LLC ($591K).
What is the short interest in LPCN?
351,433 shares were sold short at the 2026-10-15 settlement, 259.28% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.